← Leaderboards
Jim Wu
Suvalent Therapeutics, Inc.
$224,999
Attributed
$224,999
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$224,999 · 1
By mechanism
R43$224,999 · 1
Top collaborators
No co-investigators on record.
Most similar at Suvalent Therapeutics, Inc.
Same institution · by research overlap
- Shawn Xiaohu Ouyang$1,997,648
- Victor Cee$532,759
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelBaseBeta CateninBinding (Molecular Function)BiochemicalCancer CellCancer Cell LineCancer TherapyCell DeathCell LineCellsCellular AssayChemical SynthesisC-Myc GenesColorectal CancerDesignDoseDrug FormulationsDrug IndustryDrug KineticsDrug MetabolismEffective TherapyEnzyme Inhibitor DrugsAdvanced Malignant Neoplasm